Titre du document / Document title

Effects of hormone replacement therapy on weight, body composition, fat distribution, and food intake in early postmenopausal women : a prospective study

Auteur(s) / Author(s)

REUBINOFF B. E. ⁽¹⁾ ; WURTMAN J. ; ROJANSKY N. ⁽¹⁾ ; ADLER D. ; STEIN P. ; SCHENKER J. G. ⁽¹⁾ ; BRZEZINSKI A. ⁽¹⁾ ;

Affiliation(s) du ou des auteurs / Author(s) Affiliation(s)

⁽¹⁾ Hebrew univ. Hadassah medical school, dep. obstetrics gynecology, Jerusalem, ISRAEL

Résumé / Abstract

Objective : To evaluate the effects of hormone replacement therapy (HRT) on body weight and composition, fat distribution, and food intake in women entering the climacteric. Design : Prospective clinical study. Setting : Outpatient menopause clinic at a tertiary medical center. Participants : Sixty-three early postmenopausal women (44 to 54 years old) were prospectively studied for 1 year. They consisted of two groups : group A, 34 subjects who initiated continuous estrogen and progestin treatment (daily oral conjugated estrogen 0.625 mg and medroxyprogesterone acetate 2.5 mg), and group B, 29 women who refused hormonal therapy and served as controls. The age, menopausal status, initial anthropometric measurements (weight, body mass index [BMI], fat mass, and waist-to-hip girth ratio), and daily food intake (total caloric intake and food composition) were similar in both groups. Interventions : Anthropometric measurements were performed before commencement of HRT use and after 12 months. Main Outcome Measures : Anthropometric measurements included BMI, waist-to-hip girth ratio, and body composition (the percentage of body fat and water) estimated by means of infrared interactance. Daily food intake was also recorded. Results : The body weight and fat mass increased significantly in both the treatment (73.22 ± 2.01 [mean ± SE] to 75.57 ± 1.12 kg) and the control group (71.45 ± 3.11 to 73.51 ± 1.23 kg). However, a significant shift from gynoid to android fat distribution was observed only in the control group (waist-to-hip ratio shifted from 0.80 ± 0.01 to 0.85 ± 0.01), whereas no significant change was observed in the treatment group (0.81 ± 0.01 to 0.82 ± 0.01). Caloric and macronutrient intake did not change in either group. Conclusions : These results indicate that continuous daily estrogen and progestin replacement therapy neither prevents nor increases early postmenopausal weight gain and fat accumulation. However, it does minimize the shift from gynoid to android fat distribution.

Revue / Journal Title

Fertility and sterility   ISSN 0015-0282   CODEN FESTAS 

Source / Source

1995, vol. 64, n^o5, pp. 963-968 (24 ref.)

Langue / Language

Anglais

Editeur / Publisher

Elsevier, New York, NY, ETATS-UNIS  (1950) (Revue)

Mots-clés anglais / English Keywords

Replacement therapy ; Estrogen ; Progesterone ; Estroprogestagen ; Oral administration ; Postmenopause ; Body weight ; Distribution ; Food intake ; Toxicity ; Chemotherapy ; Body composition ; Adipose tissue ; Human ; Female ; Menopause ; Morphometry ; Ovarian hormone ; Sex steroid hormone ;

Mots-clés français / French Keywords

Traitement substitutif ; Oestrogène ; Progestérone ; Oestroprogestatif ; Voie orale ; Postménopause ; Poids corporel ; Distribution ; Consommation alimentaire ; Toxicité ; Chimiothérapie ; Composition corporelle ; Tissu adipeux ; Homme ; Femelle ; Ménopause ; Morphométrie ; Hormone ovarienne ; Hormone stéroïde sexuelle ;

Mots-clés espagnols / Spanish Keywords

Tratamiento sustitutivo ; Estrógeno ; Progesterona ; Estroprogestágeno ; Vía oral ; Postmenopausia ; Peso corporal ; Distribución ; Consumo alimenticio ; Toxicidad ; Quimioterapia ; Composicíon corporal ; Tejido adiposo ; Hombre ; Hembra ; Menopausia ; Morfometría ; Hormona ovárica ; Hormona esteroide sexual ;

Localisation / Location

INIST-CNRS, Cote INIST : 4120, 35400005052791.0140